UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 3, 2023
Accession Number:
0001193125-23-056527
Submission Type:
POS AM
CIK:
0001055726
Company Name:
INOVIO PHARMACEUTICALS, INC.
File Number:
333-252256